BCR and ovarian cancer: In this study, we conducted a comprehensive analysis of the TCR and BCR immune repertoires in patients with benign and malignant ovarian tumors, yielding several significant findings: (1) Patients with malignant ovarian tumors exhibited distinct immune repertoire characteristics, including reduced in balance, richness, and diversity clonotype abundance in both TCR and BCR repertoires compared to benign cases.